Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "sll"

Airtel Sierra Leone launches SLL 1.2 billion promotion

Airtel Sierra Leone has launched the Bomba Millionaire raffle draw worth SLL 1.2 billion. The two-month raffle draw began on 3 July and 20 Airtel subscribers will win SLL 1 million daily and a grand draw will award SLL 10 million every Friday. MD ... Telecompaper, 4 days ago

19 images for sll

Packet & Times, 14 hours ago
Citybizlist, 3 weeks ago
WWMT, 3 weeks ago
KSL-TV, 2 months ago
Columbus Dispatch, 2 months ago
Columbus Dispatch, 2 months ago
Broadway World, 2 months ago
MSN Philippines, 2 months ago
Pharma Letter, 3 months ago
Total Lighting, 4 months ago

Standard Life slips as Greek worries peg back Britain's FTSE

* FTSE around lowest level since late January * Greece faces defaulting on 1.6 bln euro loan * Standard Life (LSE: SL.L - news) slips after downgrade from RBC (Other OTC: RBCI - news) By Sudip Kar-Gupta LONDON, June 30 (Reuters) - Britain's top ...
 Yahoo! Finance UK and Ireland1 week ago BUZZ-View from the buyside: Premier AM switches out of Standard Life into Chesnara  Yahoo! UK and Ireland1 month ago Britain's FTSE pegged back by falls at Tesco and Standard Life  Yahoo! Finance UK and Ireland1 week ago

RBC Capital downgrades Standard Life to ''underperform'

LONDON (ShareCast) - RBC Capital Markets downgraded Standard Life (LSE: SL.L - news) to 'underperform' from 'sector perform' and cut the price target to 430p from 480p. "A comparison with asset managers indicates to us that Standard Life is ...
 Yahoo! Finance UK and Ireland1 week ago Standard Life Investments says Brexit would be disaster for capital markets  Yahoo! Finance1 week ago
Reuters India

Standard Life shuts Singapore insurance business

LONDON (Reuters) - Insurer and asset manager Standard Life (SL.L) said on Thursday it was closing its insurance operation in Singapore as it focuses on its Chinese and Indian joint ventures and its asset management business. The closure will ...
 Yahoo! Finance1 week ago

Keith Skeoch to replace David Nish as Standard Life CEO

LONDON (ShareCast) - Standard Life (LSE: SL.L - news) 's chief executive David Nish will step down on 5 August after six years in the role, to be succeeded by Keith Skeoch, who is currently chief executive of Standard Life Investments. Nish said: ...
 Yahoo! UK and Ireland2 weeks ago Standard Life Names Keith Skeoch CEO; David Nish To Resign On Aug. 5  RTTNews.com2 weeks ago
Reuters UK

Standard Life names funds chief Skeoch as new group CEO

LONDON British insurer Standard Life ( SL.L ) said on Friday Keith Skeoch, currently boss of its fund management arm, would become chief executive of the wider group, replacing David Nish, who steps down on Aug. 5. The move signifies the growing ...
 Reuters UK2 weeks ago STANDARD LIFE : names funds chief Skeoch as new group CEO  4 Traders2 weeks ago

AbbVie updates Phase 1b, open-label, dose-escalation, international study of venetoclax combined with rituximab in CLL or SLL patients

Biopharmaceutical company AbbVie The company said the updated results of a Phase 1b study showed patients with relapsed/refractory chronic lymphocytic leukemia (CLL) taking venetoclax, an investigational B-cell lymphoma 2 (BCL-2) selective ...
 Bloomberg3 weeks ago AbbVie announces encouraging results from Phase Ib CLL study  Individual.com1 week ago AbbVie reports positive results from phase 1b study of venetoclax with rituximab in patients with relapsed/refractory CLL  PharmaBiz3 weeks ago Phase 1b Study of Investigational Treatment Venetoclax with Rituximab Shows Clinical Response in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia  SOA World Magazine3 weeks ago

Ibrutinib shows promise in CLL/SLL

medwireNews: The addition of ibrutinib to bendamustine and rituximab significantly prolongs progression-free survival (PFS) in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL), according to the HELIOS trial. The ...
 MedWire News4 weeks ago
Medical News Today

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA ® ) ...
 News-Medical.Net1 month ago Pharmacyclics: Ibrutinib Increases Progression-free Survival In CLL/SLL Patients  RTTNews.com1 month ago Chronic lymphocytic leukaemia: Interim analysis data of Phase 3 HELIOS trial announced  Medical News Today1 month ago HELIOS Data Show Significant Increase in Independent Review Committee (IRC)-Assessed Progression-Free Survival (PFS) Versus Placebo in Previously-Treated Chronic Lymphocytic Leukaemia (CLL/SLL)  PharmiWeb1 month ago

New Issue- SLL-INV prices 500 mln SEK 2019 FRN

May 25 (Reuters) -Following are terms and conditions of a FRN priced on Monday. Borrower Stockholms Lans Landsting (SLL-INV) Issue Amount 500 million swedish crown Maturity Date June 3, 2019 Coupon 3 month stibor + 16 basis points Issue price ...
 Reuters1 month ago UPDATE 1-New Issue- SLL-INV prices 500 mln SEK 2019 FRN  Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less